IMTX Competitors & Alternatives
Compare Immatics NV with similar stocks in the same industry
Biotechnology
IMTX
Main Stock$9.23
Tradestie Score
56
Market Cap
$1.09B
Revenue Growth
-0.6%
Analyst Upside
+104.6%
Top Competitors
230 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
JANX
Janux Therapeutics, Inc. Common Stock
|
$16.14
|
$1.42B | - | 64 | Compare |
|
SNDX
Syndax Pharmaceuticals, Inc.
|
$22.89
|
$1.35B | - | 63 | Compare |
|
RAPP
Rapport Therapeutics, Inc. Common Stock
|
$40.59
|
$1.32B | - | 65 | Compare |
|
XERS
Xeris Biopharma Holdings, Inc. Common Stock
|
$8.16
|
$1.29B | 119.1 | 61 | Compare |
|
STOK
Stoke Therapeutics, Inc. Common Stock
|
$29.46
|
$1.29B | - | 50 | Compare |
|
ARDX
Ardelyx, Inc.
|
$5.14
|
$1.29B | - | 52 | Compare |
|
ZYME
Zymeworks Inc.
|
$24.94
|
$1.28B | - | 54 | Compare |
|
NUVB
Nuvation Bio Inc.
|
$5.77
|
$1.27B | - | 55 | Compare |
|
SION
Sionna Therapeutics, Inc. Common Stock
|
$43.95
|
$1.26B | - | 61 | Compare |
|
CVAC
CureVac N.V. Ordinary Shares
|
$4.66
|
$1.22B | 7.0 | 58 | Compare |
More IMTX Analysis
Data updated: Jul 14, 2026 | Industry: Biotechnology (SIC 2836)
230 stocks in this industry